HIGHLIGHTS
- who: . and collaborators from the University of Malaya, Malaysia have published the research work: Protective potential of hydroxysaf or yellow A in cerebral ischemia and reperfusion injury: An overview of evidence from experimental studies, in the Journal: (JOURNAL)
- what: The authors focused on the neuropharmacological properties of HSYA, the therapeutic effects of HSYA in preclinical models of ischemic stroke and the underlying mechanisms involved, as well as clinical data that support its neuroprotective action. The study was a prospective, single-blinded, and randomized controlled trial and conducted in 108 patients after informed consent and screening . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.